Related Experiment Video
Updated: Jul 3, 2026

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
Targeting DNA 5mCpG sites with chimeric endonucleases
Alexey Fomenkov1, Priscilla Hiu-Mei Too, Siu-Hong Chan
1New England Biolabs, Inc., 240 County Road. Ipswich, MA 01938-2723, USA.
Abstract:
Cytosine modification of the dinucleotide CpG in the DNA regulatory region is an important epigenetic marker during early embryo development, cellular differentiation, and cancer progression. In clinical settings, such as anti-cancer drug treatment, it is desirable to develop research tools to characterize DNA sequences affected by epigenetic perturbations. Here, we describe the construction and characterization of two fusion endonucleases consisting of the (5)mCpG-binding domain of human MeCP2 (hMeCP2) and the cleavage domains of BmrI and FokI restriction endonucleases (REases). The chimeric (CH) endonucleases cleave M.HpaII (C(5)mCGG)-and M.SssI ((5)mCpG)-modified DNA. Unmodified DNA and M.MspI-modified DNA ((5)mCCGG) are poor substrates for the CH-endonucleases. Sequencing cleavage products of modified lambda DNA indicates that cleavage takes place outside the (5)mCpG recognition sequence, predominantly 4-17 bp upstream of the modified base (/N(4-17)(5)mCpG, where / indicates the cleavage site). Such (5)mCpG-specific endonucleases will be useful to study CpG island modification of the regulatory regions of tumor suppressor genes, and for the construction of cell-specific and tumor-specific modified CpG island databases.
Insights
Researchers developed novel fusion endonucleases that specifically target and cleave methylated CpG sites in DNA. These tools aid in studying epigenetic changes in gene regulation and cancer progression.
Area of Science:
- Epigenetics
- Molecular Biology
- Biotechnology
Background:
- Cytosine modification at CpG sites is a key epigenetic marker in development and disease.
- Characterizing epigenetic alterations is crucial for anti-cancer drug development and research.
Purpose of the Study:
- To engineer novel fusion endonucleases for specific detection of DNA (5)mCpG modifications.
- To create research tools for analyzing epigenetic perturbations in DNA regulatory regions.
Main Methods:
- Construction of chimeric endonucleases by fusing the (5)mCpG-binding domain of human MeCP2 (hMeCP2) with BmrI and FokI restriction endonuclease (REase) cleavage domains.
- Characterization of the chimeric endonucleases' cleavage activity on various modified and unmodified DNA substrates.
- Sequencing of cleavage products to determine the precise cleavage site relative to the (5)mCpG modification.
Main Results:
- The developed chimeric endonucleases specifically cleave DNA modified by M.HpaII (C(5)mCGG) and M.SssI ((5)mCpG).
- Unmodified DNA and M.MspI-modified DNA ((5)mCCGG) were poorly cleaved.
- Cleavage occurred predominantly 4-17 bp upstream of the (5)mCpG site, outside the recognition sequence.
Conclusions:
- The novel (5)mCpG-specific endonucleases are effective tools for studying CpG island methylation in gene regulatory regions.
- These enzymes can be utilized for constructing cell-specific and tumor-specific modified CpG island databases.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...

